Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q419319> ?p ?o }
Showing triples 1 to 79 of
79
with 100 triples per page.
- Q419319 subject Q7310239.
- Q419319 subject Q8307291.
- Q419319 subject Q8798541.
- Q419319 subject Q8969064.
- Q419319 subject Q9052781.
- Q419319 abstract "Bortezomib (BAN, INN and USAN. Originally codenamed PS-341; marketed as Velcade by Millennium Pharmaceuticals; Neomib by SciGen Philippines and Bortecad by Cadila Healthcare) is the first therapeutic proteasome inhibitor to be tested in humans. Proteasomes are cellular complexes that break down proteins. In some cancers, the proteins that normally kill cancer cells are broken down too quickly. Bortezomib interrupts this process and lets those proteins kill the cancer cells. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease. It extends survival by about 6 months, but the U.K. health service found the original cost of £18,000 per patient to be excessive and negotiated a lower price.".
- Q419319 atcPrefix "L01".
- Q419319 atcSuffix "XX32".
- Q419319 casNumber "179324-69-7".
- Q419319 drugbank "DB00188".
- Q419319 fdaUniiCode "69G8BD63PP".
- Q419319 iupacName "[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid".
- Q419319 pubchem "387447".
- Q419319 thumbnail Bortezomib.svg?width=300.
- Q419319 wikiPageExternalLink WE_1.php.
- Q419319 wikiPageExternalLink IndexPage.action?tabId=1&menuId=151&indexPageId=53&parentLinkId=976&categoryId=172&gParentType=menuitem&gParentId=151&parentIndexPageId=47&parentCategoryId=71.
- Q419319 wikiPageExternalLink ?vgnextoid=76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview=abst_detail_view&confID=40&abstractID=31445.
- Q419319 wikiPageExternalLink default.htm.
- Q419319 wikiPageExternalLink 3.05.html.
- Q419319 wikiPageExternalLink www.velcade.com.
- Q419319 wikiPageExternalLink www.velcade.info.
- Q419319 wikiPageExternalLink www.velcadethree.co.uk.
- Q419319 wikiPageWikiLink Q1128050.
- Q419319 wikiPageWikiLink Q134856.
- Q419319 wikiPageWikiLink Q1435822.
- Q419319 wikiPageWikiLink Q147101.
- Q419319 wikiPageWikiLink Q170545.
- Q419319 wikiPageWikiLink Q1773974.
- Q419319 wikiPageWikiLink Q182155.
- Q419319 wikiPageWikiLink Q2035485.
- Q419319 wikiPageWikiLink Q204711.
- Q419319 wikiPageWikiLink Q2112244.
- Q419319 wikiPageWikiLink Q268713.
- Q419319 wikiPageWikiLink Q309110.
- Q419319 wikiPageWikiLink Q3269441.
- Q419319 wikiPageWikiLink Q335768.
- Q419319 wikiPageWikiLink Q3425168.
- Q419319 wikiPageWikiLink Q393339.
- Q419319 wikiPageWikiLink Q407693.
- Q419319 wikiPageWikiLink Q418602.
- Q419319 wikiPageWikiLink Q422252.
- Q419319 wikiPageWikiLink Q467635.
- Q419319 wikiPageWikiLink Q483745.
- Q419319 wikiPageWikiLink Q4926095.
- Q419319 wikiPageWikiLink Q5016462.
- Q419319 wikiPageWikiLink Q585285.
- Q419319 wikiPageWikiLink Q618.
- Q419319 wikiPageWikiLink Q633403.
- Q419319 wikiPageWikiLink Q640448.
- Q419319 wikiPageWikiLink Q6431240.
- Q419319 wikiPageWikiLink Q6858915.
- Q419319 wikiPageWikiLink Q7251235.
- Q419319 wikiPageWikiLink Q725307.
- Q419319 wikiPageWikiLink Q7263414.
- Q419319 wikiPageWikiLink Q7310239.
- Q419319 wikiPageWikiLink Q824258.
- Q419319 wikiPageWikiLink Q8307291.
- Q419319 wikiPageWikiLink Q864868.
- Q419319 wikiPageWikiLink Q8798541.
- Q419319 wikiPageWikiLink Q8969064.
- Q419319 wikiPageWikiLink Q9052781.
- Q419319 wikiPageWikiLink Q918753.
- Q419319 wikiPageWikiLink Q9368.
- Q419319 wikiPageWikiLink Q945238.
- Q419319 atcPrefix "L01".
- Q419319 atcSuffix "XX32".
- Q419319 casNumber "179324".
- Q419319 drugbank "DB00188".
- Q419319 iupacName "[-3-methyl-1-butyl]boronic acid".
- Q419319 pubchem "387447".
- Q419319 unii "69".
- Q419319 type ChemicalSubstance.
- Q419319 type Drug.
- Q419319 type ChemicalObject.
- Q419319 type Thing.
- Q419319 type Q8386.
- Q419319 comment "Bortezomib (BAN, INN and USAN. Originally codenamed PS-341; marketed as Velcade by Millennium Pharmaceuticals; Neomib by SciGen Philippines and Bortecad by Cadila Healthcare) is the first therapeutic proteasome inhibitor to be tested in humans. Proteasomes are cellular complexes that break down proteins. In some cancers, the proteins that normally kill cancer cells are broken down too quickly. Bortezomib interrupts this process and lets those proteins kill the cancer cells.".
- Q419319 label "Bortezomib".
- Q419319 depiction Bortezomib.svg.